VISUAL PATHWAY GLIOMA

Clinical trials for VISUAL PATHWAY GLIOMA explained in plain language.

Never miss a new study

Get alerted when new VISUAL PATHWAY GLIOMA trials appear

Sign up with your email to follow new studies for VISUAL PATHWAY GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill vs. IV chemo: race to save Kids' vision from NF1 tumors

Disease control Ongoing

This study is for children and young adults (ages 2-21) with a genetic condition called Neurofibromatosis Type 1 (NF1) who have a low-grade brain tumor. It compares a newer oral medication called selumetinib against the standard intravenous chemotherapy (carboplatin/vincristine).…

Matched conditions: VISUAL PATHWAY GLIOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

VISUAL PATHWAY GLIOMA

Get alerted when new VISUAL PATHWAY GLIOMA trials appear

New pill vs. IV chemo: race to save Kids' vision from NF1 tumors